
  
    
      
        Background_NNP
        Thymocyte_NNP development_NN occurs_VBZ within_IN a_DT complex_JJ network_NN of_IN
        cells_NNS ,_, extracellular_NN matrix_NN ,_, and_CC secreted_JJ factors_NNS referred_VBD
        to_TO as_IN the_DT thymic_JJ microenvironment_NN [_NN 1_CD ]_NN ._. Current_JJ evidence_NN
        suggests_VBZ that_IN this_DT microenvironment_NN is_VBZ created_VBN during_IN fetal_JJ
        thymus_JJ organogenesis_NNS through_IN stage-dependent_JJ interactions_NNS
        between_IN differentiating_VBG thymic_JJ epithelial_NN cells_NNS (_( TECs_NNP )_) and_CC
        developing_VBG thymocytes_NNS [_NN 2_CD 3_CD 4_CD 5_CD 6_CD ]_NN ._. Therefore_RB ,_, blocks_NNS at_IN
        different_JJ stages_NNS of_IN thymocyte_NN development_NN result_NN in_IN
        differential_NN effects_NNS on_IN TEC_NNP differentiation_NN and_CC function_NN ._.
        Because_IN of_IN the_DT complex_JJ interdependence_NN of_IN TEC_NNP and_CC thymocyte_NN
        differentiation_NN ,_, defects_NNS in_IN fetal_JJ TEC_NNP development_NN can_MD be_VB
        caused_VBN either_CC directly_RB by_IN cell-autonomous_JJ TEC_NNP
        differentiation_NN defects_NNS ,_, or_CC indirectly_RB by_IN defective_JJ
        thymocyte_NN maturation_NN ._. Once_RB a_DT mature_VBP thymic_JJ environment_NN is_VBZ
        formed_VBN ,_, many_JJ ,_, if_IN not_RB all_DT stages_NNS of_IN thymocyte_NN maturation_NN
        require_VB interactions_NNS with_IN thymic_JJ epithelial_NN cells_NNS ._.
        Therefore_RB ,_, defects_NNS in_IN TECs_NNP can_MD in_IN turn_VB cause_VB defects_NNS in_IN
        thymocyte_NN differentiation_NN ,_, proliferation_NN ,_, or_CC cell_NN
        death_NN ._.
        Thymocyte_NNP differentiation_NN undergoes_NNS two_CD main_JJ
        transitions_NNS ._. The_DT first_JJ is_VBZ from_IN the_DT CD_NNP 3_CD -_: 4_CD -_: 8_CD -_: (_( triple_JJ
        negative_NN ,_, TN_NNP )_) to_TO the_DT CD_NNP 4_CD +_NN 8_CD +_NN (_( double_JJ positive_NN ,_, DP_NNP )_) stages_NNS ._.
        During_IN this_DT transition_NN ,_, T_NN cell_NN precursors_NNS sequentially_RB gain_VBP
        and_CC lose_VB cell_NN surface_NN expression_NN of_IN CD_NNP 44_CD and_CC CD_NNP 25_CD markers_NNS ,_,
        express_VBP the_DT pre-_NN T_NN cell_NN receptor_NN (_( pTCR_NN )_) ,_, and_CC undergo_VBP
        β-selection_JJ [_NN 2_CD 7_CD 8_CD 9_CD ]_NN ._. The_DT other_JJ transition_NN is_VBZ from_IN CD_NNP 4_CD
        +_NN 8_CD +_NN DP_NNP to_TO CD_NNP 4_CD +_NN or_CC CD_NNP 8_CD +_NN single_JJ positive_JJ (_( SP_NNP )_) thymocytes_NNS ,_, in_IN
        which_WDT DP_NNP cells_NNS express_VBP CD_NNP 3_CD ,_, rearrange_VB their_PRP$ α-_NN TCR_NNP ,_, undergo_VBP
        positive_JJ and_CC negative_JJ selection_NN ,_, and_CC down_RB regulate_VB CD_NNP 4_CD or_CC
        CD_NNP 8_CD to_TO become_VB functional_JJ CD_NNP 8_CD +_NN or_CC CD_NNP 4_CD +_NN SP_NNP T_NN cells_NNS [_NN 10_CD 11_CD ]_NN
        ._. In_IN addition_NN to_TO functional_JJ and_CC cell_NN surface_NN marker_NN
        changes_NNS ,_, each_DT thymocyte_NN differentiation_NN stage_NN is_VBZ marked_VBN by_IN
        characteristic_JJ changes_NNS in_IN proliferation_NN and_CC apoptosis_NNS [_NN 12_CD
        13_CD 14_CD 15_CD 16_CD 17_CD 18_CD ]_NN ._.
        The_DT most_RBS well_RB defined_VBN role_NN for_IN TECs_NNP in_IN directly_RB
        affecting_VBG thymocyte_NN differentiation_NN is_VBZ to_TO mediate_VB positive_JJ
        selection_NN via_IN expression_NN of_IN MHC_NNP molecules_NNS [_NN 11_CD 19_CD 20_CD 21_CD 22_CD
        ]_NN ._. However_RB ,_, it_PRP is_VBZ still_RB unclear_JJ whether_IN TECs_NNP directly_RB
        promote_VBP specific_JJ stages_NNS of_IN thymocyte_NN differentiation_NN during_IN
        stages_NNS that_WDT do_VBP not_RB involve_VB MHC-TCR_NNP interactions_NNS ,_, or_CC whether_IN
        their_PRP$ role_NN at_IN other_JJ stages_NNS is_VBZ primarily_RB to_TO promote_VB cell_NN
        growth_NN and_CC /_NN or_CC survival_NN ._. Cytokines_NNP produced_VBN by_IN TECs_NNP have_VBP
        been_VBN shown_VBN to_TO promote_VB proliferation_NN in_IN early_JJ stages_NNS of_IN
        thymocyte_NN development_NN ,_, and_CC have_VBP been_VBN proposed_VBN to_TO regulate_VB
        apoptosis_NNS and_CC differentiation_NN ,_, although_IN their_PRP$ precise_JJ roles_NNS
        remain_VBP controversial_JJ [_NN 23_CD 24_CD ]_NN ._. TECs_NNP have_VBP also_RB been_VBN shown_VBN
        to_TO promote_VB thymocyte_NN proliferation_NN in_IN SP_NNP cells_NNS after_IN
        selection_NN has_VBZ occurred_VBN [_NN 15_CD ]_NN ._. However_RB ,_, a_DT defined_VBN role_NN for_IN
        TECs_NNP at_IN the_DT TN-DP_NNP transition_NN remains_VBZ elusive_JJ ._. Much_JJ of_IN the_DT
        research_NN on_IN this_DT transition_NN has_VBZ focused_VBN on_IN the_DT role_NN of_IN the_DT
        pre-_NN TCR_NNP ._. Mounting_NNP evidence_NN suggests_VBZ that_IN the_DT pre-_NN TCR_NNP does_VBZ
        not_RB require_VB interaction_NN with_IN a_DT ligand_NN to_TO perform_VB its_PRP$
        function_NN ,_, and_CC the_DT subsequent_JJ CD_NNP 44_CD -_: 25_CD -_: (_( TN_NNP 4_CD or_CC pre-_NN DP_NNP )_) to_TO
        DP_NNP transition_NN has_VBZ been_VBN termed_VBN "_'' programmed_VBN differentiation_NN "_''
        to_TO indicate_VB that_IN this_DT step_NN can_MD occur_VB in_IN isolated_VBN
        thymocytes_NNS ,_, presumably_RB without_IN input_NN from_IN extrinsic_JJ signals_NNS
        [_NN 25_CD 26_CD 27_CD ]_NN ._. However_RB ,_, there_EX is_VBZ also_RB evidence_NN that_IN the_DT
        thymic_JJ microenvironment_NN does_VBZ contribute_VB signals_NNS required_VBN
        for_IN the_DT TN-DP_NNP transition_NN ,_, particularly_RB to_TO promote_VB thymocyte_NN
        proliferation_NN and_CC apoptosis_NNS [_NN 13_CD 28_CD 29_CD 30_CD ]_NN ._. The_DT specific_JJ
        nature_NN and_CC purpose_NN of_IN the_DT TEC_NNP contribution_NN during_IN this_DT
        important_JJ transition_NN therefore_RB remains_VBZ to_TO be_VB
        determined_VBN ._.
        In_IN order_NN to_TO investigate_VB the_DT regulation_NN of_IN thymocyte_NN
        development_NN by_IN TECs_NNP ,_, we_PRP are_VBP studying_VBG 
        Hoxa_NNP 3_CD +_NN /_NN -_: 
        Pax_NNP 1_CD -_: /_NN -_: compound_NN mutant_JJ mice_NNS ._. Hoxa_NNP 3_CD
        and_CC Pax_NNP 1_CD are_VBP transcription_NN factors_NNS that_WDT act_NN in_IN a_DT common_JJ
        pathway_NN regulating_VBG thymus_JJ organogenesis_NNS and_CC thymic_JJ
        epithelial_NN cell_NN development_NN [_NN 29_CD 31_CD 32_CD 33_CD 34_CD ]_NN ._. 
        Hoxa_NNP 3_CD +_NN /_NN -_: 
        Pax_NNP 1_CD -_: /_NN -_: compound_NN mutants_NNS have_VBP defects_NNS
        in_IN TEC_NNP development_NN including_VBG reduced_VBN numbers_NNS of_IN TECs_NNP ,_, fewer_JJR
        MHC_NNP Class_NNP II_NNP +_NN TECs_NNP ,_, and_CC changes_NNS in_IN TEC_NNP proliferation_NN and_CC
        apoptosis_NNS ._. These_DT TEC_NNP defects_NNS result_VBP in_IN thymocyte_NN maturation_NN
        defects_NNS that_WDT include_VBP a_DT decrease_NN in_IN total_JJ thymocyte_NN number_NN
        and_CC a_DT 10_CD -_: fold_VB reduction_NN in_IN the_DT number_NN of_IN DP_NNP thymocytes_NNS ,_, but_CC
        an_DT apparently_RB normal_JJ transition_NN from_IN the_DT TN_NNP 3_CD to_TO the_DT pre-_NN DP_NNP
        stage_NN ._. The_DT decrease_NN in_IN DP_NNP cells_NNS is_VBZ associated_VBN with_IN
        increased_VBN apoptosis_NNS in_IN both_DT pre-_NN DP_NNP and_CC DP_NNP cells_NNS [_NN 29_CD ]_NN ._. As_IN
        the_DT defects_NNS at_IN the_DT TN_NNP to_TO DP_NNP transition_NN in_IN these_DT mutants_NNS are_VBP
        caused_VBN by_IN defective_JJ TEC_NNP function_NN rather_RB than_IN
        thymocyte-intrinsic_JJ defects_NNS ,_, these_DT mice_NNS represent_VBP an_DT
        opportunity_NN to_TO study_VB the_DT role_NN of_IN TECs_NNP in_IN promoting_VBG this_DT
        transition_NN ._.
        To_TO further_VB investigate_VB the_DT role_NN of_IN TECs_NNP in_IN promoting_VBG
        thymocyte_NN death_NN and_CC growth_NN during_IN the_DT TN_NNP to_TO DP_NNP transition_NN ,_,
        we_PRP assayed_JJ the_DT proliferation_NN of_IN specific_JJ thymocyte_NN subsets_NNS
        using_VBG BrdU_NNP incorporation_NN ,_, which_WDT detects_NNS cycling_NN cells_NNS in_IN
        S-_NNP phase_NN ._. We_PRP compared_VBD fetal_JJ and_CC adult_NN wild_JJ type_NN mice_NNS with_IN 
        Hoxa_NNP 3_CD ,_, Pax_NNP 1_CD compound_NN mutants_NNS [_NN 29_CD 34_CD ]_NN
        ._. We_PRP also_RB assayed_JJ 
        Rag_NNP 1_CD -_: /_NN -_: mice_NNS ,_, which_WDT have_VBP defects_NNS in_IN
        TEC_NNP development_NN due_JJ to_TO arrested_VBN thymocyte_NN maturation_NN at_IN the_DT
        TN_NNP 3_CD stage_NN [_NN 35_CD ]_NN ._. We_PRP found_VBD stage-specific_JJ differences_NNS in_IN
        proliferation_NN levels_NNS between_IN fetal_JJ and_CC adult_NN wild_JJ type_NN
        thymocytes_NNS ._. We_PRP also_RB found_VBD distinct_JJ patterns_NNS of_IN thymocyte_NN
        proliferation_NN in_IN the_DT 
        Rag_NNP 1_CD -_: /_NN -_: and_CC 
        Hoxa_NNP 3_CD ,_, Pax_NNP 1_CD mutants_NNS ._. The_DT abnormal_JJ cell_NN
        death_NN and_CC proliferation_NN patterns_NNS in_IN the_DT 
        Hoxa_NNP 3_CD ,_, Pax_NNP 1_CD compound_NN mutant_JJ fetal_JJ
        thymocytes_NNS might_MD be_VB caused_VBN in_IN part_NN by_IN observed_VBD reductions_NNS
        in_IN the_DT transcription_NN levels_NNS of_IN the_DT cytokines_NNS IL-_NNP 7_CD and_CC SCF_NNP
        produced_VBN by_IN TECs_NNP ._. Our_PRP$ results_NNS support_VBP a_DT critical_JJ role_NN for_IN
        microenvironment_NN created_VBN by_IN TECs_NNP in_IN regulating_VBG thymocyte_NN
        proliferation_NN during_IN the_DT TN_NNP to_TO DP_NNP transition_NN ,_, and_CC show_NN that_IN
        this_DT function_NN is_VBZ disrupted_VBN in_IN 
        Hoxa_NNP 3_CD ,_, Pax_NNP 1_CD compound_NN mutants_NNS ._.
      
      
        Results_NNS
        
          Thymocyte_NNP proliferation_NN patterns_NNS are_VBP different_JJ in_IN
          fetal_JJ and_CC adult_NN wild_JJ type_NN mice_NNS
          As_IN an_DT initial_JJ analysis_NN ,_, we_PRP compared_VBD thymocyte_NN
          proliferation_NN between_IN thymocytes_NNS from_IN late_JJ fetal_JJ (_( E_NNP 17_CD ._. 5_LS )_)
          and_CC adult_NN (_( 6_CD -_: 8_CD week_NN )_) wild_JJ type_NN C_NNP 57_CD BL_NNP 6_CD /_NN J_NNP mice_NNS ._. Although_IN
          differences_NNS in_IN the_DT proliferation_NN of_IN fetal_JJ vs_NNS ._. adult_NN
          TCR-expressing_NNP thymocytes_NNS and_CC have_VBP been_VBN reported_VBN [_NN 36_CD ]_NN ,_,
          we_PRP were_VBD interested_JJ in_IN investigating_VBG the_DT more_JJR immature_NN
          thymocyte_NN subsets_NNS ._. BrdU_NNP labeled_VBD fetal_JJ and_CC adult_NN thymi_NN
          were_VBD analyzed_VBN for_IN the_DT percent_NN of_IN proliferating_VBG cells_NNS in_IN
          different_JJ CD_NNP 3_CD -_: 4_CD -_: 8_CD -_: TN_NNP thymocyte_NN subsets_NNS defined_VBN by_IN CD_NNP 44_CD
          and_CC CD_NNP 25_CD expression_NN [_NN 8_CD ]_NN ._. The_DT CD_NNP 3_CD +_NN 4_CD +_NN 8_CD +_NN population_NN was_VBD
          defined_VBN by_IN co-staining_JJ of_IN all_DT three_CD markers_NNS (_( Fig_NNP ._. 1_LS A_DT )_) ._. A_DT
          typical_JJ analysis_NN of_IN the_DT BrdU_NNP +_NN cells_NNS in_IN DP_NNP cells_NNS and_CC the_DT
          four_CD CD_NNP 44_CD vs_NNS ._. CD_NNP 25_CD subsets_NNS within_IN the_DT TN_NNP cell_NN population_NN
          is_VBZ shown_VBN in_IN Figure_NN 1_CD ._. Compiled_VBN data_NNS for_IN each_DT subset_NN from_IN
          all_DT experiments_NNS is_VBZ shown_VBN in_IN Table_NNP 1_CD ._.
          The_DT wild_JJ type_NN adult_NN (_( Fig_NNP ._. 1_LS C_NNP ,_, 1_CD F_NN )_) and_CC fetal_JJ (_( Fig_NNP ._. 1_LS D_NNP ,_,
          1_CD F_NN )_) thymocyte_NN proliferation_NN profile_NN patterns_NNS differed_VBD
          significantly_RB at_IN specific_JJ stages_NNS ._. The_DT overall_JJ
          proliferation_NN level_NN in_IN TN_NNP cells_NNS was_VBD increased_VBN by_IN 50_CD %_NN in_IN
          fetal_JJ thymocytes_NNS (_( p_NN <_NN 0_CD ._. 01_CD )_) ._. Most_JJS dramatically_RB ,_, the_DT
          percentages_NNS of_IN BrdU_NNP +_NN cells_NNS in_IN fetal_JJ thymocytes_NNS were_VBD
          10_CD -_: fold_VB higher_JJR than_IN in_IN the_DT adult_NN at_IN the_DT earliest_JJS ,_, TN_NNP 1_CD
          (_( CD_NNP 44_CD +_NN 25_CD -_: )_) thymocyte_NN differentiation_NN stage_NN (_( P_NN <_NN
          0_CD ._. 001_CD )_) ._. A_DT much_RB lower_RBR ,_, but_CC still_RB significant_JJ increase_NN was_VBD
          seen_VBN in_IN fetal_JJ TN_NNP 2_CD cells_NNS (_( 25_CD %_NN increase_NN ,_, p_NN <_NN 0_CD ._. 01_CD )_) ._.
          Proliferation_NNP was_VBD also_RB significantly_RB higher_JJR at_IN the_DT fetal_JJ
          TN_NNP 3_CD stage_NN compared_VBN to_TO adult_NN (_( 50_CD %_NN increase_NN ,_, p_NN <_NN 0_CD ._. 01_CD )_) ._.
          Proliferation_NNP at_IN the_DT TN_NNP 4_CD /_NN pre-_NN DP_NNP (_( CD_NNP 44_CD -_: 25_CD -_: )_) stage_NN was_VBD
          similar_JJ between_IN fetal_JJ and_CC adult_NN thymocytes_NNS ._. In_IN contrast_NN ,_,
          DP_NNP cells_NNS showed_VBD a_DT 3_CD -_: fold_VB increase_NN in_IN proliferation_NN in_IN the_DT
          fetal_JJ thymus_JJ relative_NN to_TO adult_NN (_( p_NN <_NN 0_CD ._. 01_CD )_) ._. Therefore_RB ,_,
          nearly_RB every_DT stage_NN from_IN the_DT earliest_JJS TN_NNP to_TO the_DT DP_NNP stages_NNS
          showed_VBD significantly_RB increased_VBN proliferation_NN in_IN fetal_JJ
          thymocytes_NNS relative_JJ to_TO adults_NNS ._.
          It_PRP was_VBD possible_JJ that_IN the_DT lower_JJR percentage_NN of_IN
          proliferating_VBG cells_NNS seen_VBN in_IN the_DT TN_NNP 1_CD population_NN in_IN adults_NNS
          was_VBD due_JJ to_TO an_DT increased_VBN number_NN of_IN B_NNP cells_NNS and_CC NK_NNP cells_NNS in_IN
          the_DT adult_NN thymus_JJ ,_, which_WDT would_MD not_RB have_VB been_VBN excluded_VBN in_IN
          our_PRP$ initial_JJ analysis_NN ._. As_IN this_DT was_VBD one_CD of_IN the_DT most_RBS
          striking_JJ differences_NNS seen_VBN between_IN fetal_JJ and_CC adult_NN stages_NNS ,_,
          we_PRP repeated_VBD this_DT analysis_NN adding_VBG antibodies_NNS against_IN B_NNP 220_CD
          and_CC NK_NNP 1_CD ._. 1_LS to_TO CD_NNP 3_CD ,_, 4_CD and_CC 8_CD in_IN the_DT excluded_VBN gate_NN (_( Fig_NNP ._. 1_LS G_NNP ,_,
          1_CD H_NNP )_) ._. Even_RB excluding_VBG these_DT cell_NN populations_NNS ,_, there_EX is_VBZ
          still_RB a_DT significantly_RB lower_JJR percentage_NN of_IN proliferating_VBG
          cells_NNS in_IN the_DT TN_NNP 1_CD population_NN in_IN the_DT adult_NN thymus_JJ than_IN in_IN
          the_DT fetal_JJ thymus_JJ (_( Fig_NNP ._. 1_LS I_PRP )_) ._. Therefore_RB ,_, this_DT difference_NN is_VBZ
          not_RB due_JJ to_TO different_JJ numbers_NNS of_IN B_NNP and_CC NK_NNP cells_NNS in_IN the_DT
          adult_NN vs_NNS ._. fetal_JJ thymus_JJ ._.
        
        
          Rag_NNP 1_CD -_: /_NN -_: fetal_JJ thymocytes_NNS have_VBP a_DT stage-specific_JJ
          increase_NN in_IN proliferation_NN relative_JJ to_TO wild_JJ type_NN
          We_PRP also_RB compared_VBD proliferation_NN of_IN fetal_JJ thymocytes_NNS
          from_IN 
          Rag_NNP 1_CD -_: /_NN -_: mice_NNS to_TO the_DT results_NNS
          obtained_VBN from_IN wild_JJ type_NN mice_NNS ._. Thymocytes_NNP in_IN the_DT adult_JJ 
          Rag_NNP 1_CD -_: /_NN -_: thymus_JJ have_VBP been_VBN previously_RB
          shown_VBN to_TO have_VB overall_JJ lower_JJR levels_NNS of_IN proliferation_NN than_IN
          adult_NN wild_JJ type_NN TN_NNP thymocytes_NNS [_NN 13_CD ]_NN ,_, particularly_RB at_IN
          the_DT TN_NNP 3_CD stage_NN [_NN 37_CD 38_CD 39_CD 40_CD ]_NN ._. At_IN fetal_JJ stages_NNS ,_, our_PRP$
          results_NNS showed_VBD that_DT proliferation_NN also_RB varied_VBD between_IN
          thymocytes_NNS in_IN the_DT wild_JJ type_NN and_CC 
          Rag_NNP 1_CD -_: /_NN -_: thymus_JJ at_IN discrete_JJ stages_NNS
          of_IN thymocyte_NN differentiation_NN ._. At_IN the_DT earliest_JJS TN_NNP 1_CD stage_NN ,_,
          thymocyte_NN proliferation_NN levels_NNS in_IN 
          Rag_NNP 1_CD -_: /_NN -_: thymi_NN were_VBD similar_JJ to_TO fetal_JJ
          wild_JJ type_NN cells_NNS (_( Fig_NNP ._. 1_LS E_NNP ,_, 1_CD F_NN ;_: Table_NNP 1_LS )_) ._. At_IN the_DT TN_NNP 2_CD stage_NN ,_,
          fetal_JJ thymocytes_NNS from_IN 
          Rag_NNP 1_CD -_: /_NN -_: mice_NNS had_VBD a_DT proliferation_NN
          level_NN nearly_RB twice_RB that_IN of_IN wild_JJ type_NN fetal_JJ thymocytes_NNS (_( p_NN
          <_NN 0_CD ._. 001_CD )_) ._. By_IN the_DT TN_NNP 3_CD stage_NN ,_, the_DT percentage_NN of_IN
          proliferating_VBG 
          Rag_NNP 1_CD -_: /_NN -_: thymocytes_NNS had_VBD dropped_VBN
          slightly_RB below_IN that_DT of_IN wild_JJ type_NN fetal_JJ thymocytes_NNS (_( ~_NN 30_CD %_NN
          decrease_NN ,_, p_NN <_NN 0_CD ._. 01_CD )_) ,_, equal_JJ to_TO wild_JJ type_NN adult_NN TN_NNP 3_CD
          proliferation_NN levels_NNS ._. In_IN addition_NN ,_, the_DT percentages_NNS of_IN
          BrdU_NNP +_NN cells_NNS in_IN TN_NNP 1_CD and_CC TN_NNP 2_CD subsets_NNS in_IN the_DT 
          Rag_NNP 1_CD -_: /_NN -_: fetal_JJ thymus_JJ were_VBD
          significantly_RB higher_JJR than_IN those_DT of_IN the_DT wild_JJ type_NN adults_NNS
          (_( P_NN <_NN 0_CD ._. 001_CD )_) ._. These_DT results_NNS with_IN 
          Rag_NNP 1_CD -_: /_NN -_: fetal_JJ thymocytes_NNS contrast_VBP
          with_IN thymocytes_NNS in_IN the_DT 
          Rag_NNP -_: /_NN -_: adult_NN ,_, which_WDT have_VBP much_RB lower_JJR
          proliferation_NN than_IN wild_JJ type_NN adult_NN thymocytes_NNS at_IN all_DT
          stages_NNS of_IN thymocyte_NN differentiation_NN [_NN 13_CD ]_NN ._.
        
        
          Thymocyte_NNP proliferation_NN in_IN Hoxa_NNP 3_CD +_NN /_NN -_: Pax_NNP 1_CD
          -_: /_NN -_: thymocytes_NNS at_IN the_DT TN-DP_NNP transition_NN
          Our_PRP$ previous_JJ analysis_NN of_IN the_DT 
          Hoxa_NNP 3_CD +_NN /_NN -_: 
          Pax_NNP 1_CD -_: /_NN -_: compound_NN mutant_JJ thymocyte_NN
          phenotype_NN showed_VBD a_DT specific_JJ partial_JJ block_NN at_IN the_DT TN_NNP to_TO DP_NNP
          transition_NN ,_, associated_VBN with_IN increased_VBN apoptosis_NNS at_IN both_DT
          the_DT TN_NNP 4_CD /_NN pre-_NN DP_NNP and_CC DP_NNP subsets_NNS ,_, and_CC a_DT 10_CD -_: fold_VB decrease_VB in_IN
          DP_NNP cell_NN numbers_NNS [_NN 29_CD ]_NN ._. Using_VBG BrdU_NNP analysis_NN ,_, we_PRP compared_VBD
          the_DT proliferation_NN of_IN 
          Hoxa_NNP 3_CD +_NN /_NN -_: 
          Pax_NNP 1_CD -_: /_NN -_: fetal_JJ thymocytes_NNS during_IN the_DT
          TN_NNP to_TO DP_NNP transition_NN compared_VBN to_TO littermate_NN controls_NNS ._.
          Thymocyte_NNP proliferation_NN levels_NNS for_IN all_DT genotypes_NNS (_( 
          Hoxa_NNP 3_CD +_NN /_NN -_: ,_, 
          Pax_NNP 1_CD +_NN /_NN -_: ,_, 
          Pax_NNP 1_CD -_: /_NN -_: ,_, and_CC 
          Hoxa_NNP 3_CD +_NN /_NN -_: 
          Pax_NNP 1_CD -_: /_NN -_: )_) were_VBD similar_JJ to_TO wild_JJ type_NN
          in_IN all_DT of_IN the_DT canonical_JJ TN_NNP 1_CD -_: TN_NNP 4_CD stages_NNS (_( Fig_NNP ._. 2_LS A_DT ,_, 2_CD B_NNP ,_, 2_CD C_NNP ;_:
          Table_NNP 1_LS )_) ,_, consistent_JJ with_IN the_DT normal_JJ percentages_NNS and_CC cell_NN
          numbers_NNS for_IN these_DT subpopulations_NNS previously_RB reported_VBD [_NN 29_CD
          ]_NN ._. Recent_JJ papers_NNS by_IN Penit_NNP ,_, et_CC al_NN ._. have_VBP provided_VBN data_NNS
          from_IN cell_NN cycle_NN analysis_NN suggesting_VBG that_IN a_DT discrete_JJ CD_NNP 44_CD
          -_: 25_CD lopopulation_NN with_IN a_DT specific_JJ proliferation_NN profile_NN
          can_MD be_VB identified_VBN ,_, such_JJ that_IN the_DT transition_NN from_IN TN_NNP 3_CD to_TO
          DP_NNP can_MD be_VB further_JJ subdivided_JJ into_IN CD_NNP 25_CD hi_NN ,_, CD_NNP 25_CD lo_NN ,_, and_CC
          CD_NNP 25_CD -_: subsets_NNS [_NN 12_CD 13_CD ]_NN ._. Analysis_NNP of_IN proliferation_NN using_VBG
          these_DT more_RBR narrowly_RB defined_VBN subsets_NNS still_RB showed_VBD values_NNS
          similar_JJ to_TO wild_JJ type_NN in_IN the_DT CD_NNP 44_CD -_: 25_CD losubset_NN (_( Fig_NNP ._.
          2_LS D_NNP ,_, 2_CD E_NNP ,_, 2_CD F_NN ;_: Table_NNP 2_LS )_) ._. In_IN contrast_NN ,_, the_DT proliferation_NN level_NN
          of_IN DP_NNP cells_NNS increased_VBN nearly_RB 2_CD -_: fold_VB in_IN compound_NN mutants_NNS
          compared_VBN to_TO wild_JJ type_NN (_( Fig_NNP ._. 2_LS C_NNP ,_, 2_CD F_NN ;_: Table_NNP 1_LS )_) ._. In_IN spite_NN of_IN
          this_DT increase_NN in_IN the_DT percentage_NN of_IN proliferating_VBG cells_NNS ,_,
          the_DT actual_JJ number_NN of_IN BrdU_NNP +_NN DP_NNP cells_NNS was_VBD reduced_VBN 4_CD -_: fold_VB
          compared_VBN to_TO wild_JJ type_NN in_IN the_DT compound_NN mutants_NNS (_( 15_CD ._. 03_CD ±_NN
          8_CD ._. 73_CD ×_NN 10_CD 4_CD vs_NNS ._. 61_CD ._. 94_CD ±_NN 32_CD ._. 12_CD ×_NN 10_CD 4_CD in_IN wild_JJ type_NN ;_: p_NN <_NN
          0_CD ._. 01_CD )_) ._. The_DT numbers_NNS of_IN proliferating_VBG cells_NNS at_IN the_DT pre-_NN DP_NNP
          stage_NN were_VBD unchanged_JJ (_( not_RB shown_VBN )_) ._. Combined_VBN with_IN our_PRP$
          previous_JJ results_NNS ,_, this_DT result_NN shows_VBZ that_IN both_DT increased_VBN
          apoptosis_NNS and_CC reduced_VBN proliferation_NN contribute_VB to_TO the_DT
          decrease_NN in_IN DP_NNP cells_NNS in_IN the_DT 
          Hoxa_NNP 3_CD ,_, Pax_NNP 1_CD compound_NN mutants_NNS ._.
          Unfortunately_RB ,_, 
          Hoxa_NNP 3_CD +_NN /_NN -_: 
          Pax_NNP 1_CD -_: /_NN -_: mice_NNS die_VBP at_IN birth_NN ,_,
          preventing_VBG analysis_NN of_IN thymocyte_NN proliferation_NN in_IN adult_NN
          compound_NN mutants_NNS ._.
        
        
          Cytokine_NNP production_NN is_VBZ decreased_VBN in_IN the_DT Hoxa_NNP 3_CD +_NN /_NN -_:
          Pax_NNP 1_CD -_: /_NN -_: fetal_JJ thymus_JJ
          Cytokines_NNP produced_VBN by_IN TECs_NNP are_VBP good_JJ candidates_NNS for_IN
          mediating_VBG at_IN least_JJS some_DT of_IN these_DT changes_NNS in_IN thymocyte_NN
          proliferation_NN and_CC apoptosis_NNS in_IN the_DT 
          Hoxa_NNP 3_CD ,_, Pax_NNP 1_CD compound_NN mutants_NNS ._. Using_VBG
          semi-quantitative_JJ RT-PCR_NNP ,_, we_PRP analyzed_VBD the_DT expression_NN of_IN
          two_CD cytokines_NNS that_WDT are_VBP produced_VBN by_IN TECs_NNP ,_, IL-_NNP 7_CD and_CC SCF_NNP ,_, in_IN
          pooled_VBN ,_, genotype-matched_JJ E_NNP 14_CD ._. 5_LS thymi_NN (_( Fig_NNP ._. 3_LS )_) ._. 
          Hoxa_NNP 3_CD +_NN /_NN -_: 
          Pax_NNP 1_CD -_: /_NN -_: compound_NN mutants_NNS had_VBD
          decreased_VBN transcription_NN of_IN both_DT cytokines_NNS relative_JJ to_TO all_DT
          other_JJ genotypes_NNS ,_, including_VBG 
          Pax_NNP 1_CD -_: /_NN -_: single_JJ mutants_NNS ._. However_RB ,_, 
          Hoxa_NNP 3_CD +_NN /_NN -_: 
          Pax_NNP 1_CD -_: /_NN -_: compound_NN mutants_NNS were_VBD not_RB
          completely_RB missing_VBG either_CC cytokine_NN analyzed_VBD ,_, and_CC the_DT
          magnitude_NN of_IN the_DT decrease_NN was_VBD variable_JJ between_IN pools_NNS ._.
          To_TO test_VB whether_IN the_DT changes_NNS in_IN cytokine_NN levels_NNS were_VBD
          responsible_JJ for_IN the_DT observed_VBN thymocyte_NN development_NN
          phenotypes_NNS ,_, we_PRP attempted_VBD to_TO rescue_VB these_DT phenotypes_NNS by_IN
          supplementation_NN in_IN fetal_JJ thymic_JJ organ_NN culture_NN (_( FTOC_NNP )_) ._.
          E_NNP 15_CD ._. 5_LS embryonic_JJ thymic_JJ lobes_NNS from_IN individual_JJ embryos_NNS were_VBD
          cultured_JJ separately_RB in_IN FTOC_NNP ,_, with_IN or_CC without_IN added_VBD IL-_NNP 7_CD
          or_CC SCF_NNP ._. Cultures_NNP from_IN control_NN genotypes_NNS (_( wild_JJ type_NN ,_, 
          Pax_NNP 1_CD +_NN /_NN -_: ,_, 
          Hoxa_NNP 3_CD +_NN /_NN -_: ,_, 
          Pax_NNP 1_CD -_: /_NN -_: )_) behaved_VBD as_IN expected_VBN [_NN 41_CD
          42_CD 43_CD 44_CD 45_CD 46_CD ]_NN ,_, with_IN addition_NN of_IN IL-_NNP 7_CD causing_VBG an_DT
          increase_NN in_IN the_DT percentage_NN of_IN DN_NNP cells_NNS and_CC a_DT
          corresponding_JJ decrease_NN in_IN DP_NNP cells_NNS ,_, while_IN adding_VBG SCF_NNP had_VBD
          no_DT significant_JJ effect_NN on_IN thymocyte_NN development_NN (_( data_NNS not_RB
          shown_VBN )_) ._. However_RB ,_, to_TO our_PRP$ surprise_NN the_DT two_CD separated_JJ lobes_NNS
          from_IN 
          Hoxa_NNP 3_CD +_NN /_NN -_: 
          Pax_NNP 1_CD -_: /_NN -_: compound_NN mutants_NNS did_VBD not_RB
          always_RB develop_VB in_IN predictable_JJ ways_NNS ._. In_IN fact_NN ,_, separated_JJ
          lobes_NNS cultured_JJ under_IN identical_JJ conditions_NNS in_IN the_DT absence_NN
          of_IN any_DT added_VBN cytokines_NNS had_VBD widely_RB differing_VBG results_NNS ._.
          Changes_NNS in_IN thymocyte_NN cell_NN number_NN and_CC differentiation_NN
          after_IN culture_NN were_VBD highly_RB variable_JJ ;_: for_IN example_NN ,_, cell_NN
          numbers_NNS could_MD differ_VB stochastically_RB after_IN culture_NN by_IN as_RB
          much_JJ as_IN 10_CD -_: fold_VB between_IN two_CD lobes_NNS from_IN the_DT same_JJ compound_NN
          mutant_JJ embryo_NN ._. This_DT result_NN was_VBD never_RB obtained_VBN with_IN
          separately_RB cultured_JJ thymic_JJ lobes_NNS from_IN any_DT other_JJ genotype_NN ,_,
          which_WDT always_RB developed_VBN identically_RB when_WRB cultured_JJ without_IN
          cytokines_NNS ._. This_DT property_NN of_IN the_DT compound_NN mutant_JJ thymic_JJ
          lobes_NNS probably_RB reflects_VBZ phenotypic_JJ variability_NN previously_RB
          seen_VBN in_IN our_PRP$ histological_JJ and_CC gross_JJ morphological_JJ analysis_NN
          of_IN these_DT mutants_NNS [_NN 29_CD 34_CD ]_NN ._.
        
      
      
        Discussion_NNP
        In_IN this_DT study_NN ,_, we_PRP have_VBP examined_VBN thymocyte_NN proliferation_NN
        in_IN the_DT fetal_JJ and_CC adult_NN wild_JJ type_NN thymus_JJ ._. Our_PRP$ results_NNS showed_VBD
        clear_JJ stage-specific_JJ differences_NNS in_IN wild_JJ type_NN thymocyte_NN
        proliferation_NN depending_VBG on_IN the_DT developmental_NN age_NN of_IN the_DT
        microenvironment_NN (_( i_NNP ._. e_SYM ._. fetal_JJ vs_NNS ._. adult_NN )_) ._. We_PRP also_RB analyzed_VBD
        two_CD mutant_JJ strains_NNS that_WDT have_VBP either_DT cell-autonomous_JJ (_( 
        Hoxa_NNP 3_CD +_NN /_NN -_: 
        Pax_NNP 1_CD -_: /_NN -_: )_) or_CC non-cell-autonomous_JJ (_( 
        Rag_NNP 1_CD -_: /_NN -_: )_) TEC_NNP defects_NNS ,_, with_IN blocks_NNS at_IN
        different_JJ stages_NNS of_IN thymocyte_NN differentiation_NN ._. Abnormal_NNP TEC_NNP
        development_NN in_IN both_DT of_IN these_DT mutant_JJ strains_NNS resulted_VBD in_IN
        both_DT increases_NNS and_CC decreases_NNS in_IN thymocyte_NN proliferation_NN in_IN
        a_DT stage-specific_JJ manner_NN ,_, rather_RB than_IN simply_RB an_DT overall_RB
        reduced_VBN ability_NN to_TO promote_VB proliferation_NN ._.
        There_EX is_VBZ considerable_JJ evidence_NN that_IN thymopoiesis_NNS differs_VBZ
        in_IN the_DT fetal_JJ thymus_JJ during_IN the_DT initial_JJ creation_NN of_IN the_DT
        microenvironment_NN ,_, as_IN opposed_VBN to_TO adult_NN thymus_JJ function_NN
        (_( reviewed_VBN in_IN [_NN 47_CD ]_NN )_) ._. Differences_NNS have_VBP been_VBN reported_VBN in_IN
        responses_NNS to_TO some_DT cytokines_NNS ,_, in_IN signaling_VBG at_IN the_DT TN-DP_NNP
        transition_NN in_IN fetal_JJ compared_VBN to_TO adult_NN thymus_JJ ,_, and_CC in_IN
        proliferation_NN of_IN CD_NNP 4_CD +_NN SP_NNP thymocytes_NNS [_NN 36_CD 48_CD 49_CD 50_CD ]_NN ._. The_DT
        proliferation_NN profiles_NNS of_IN both_DT wild_JJ type_NN and_CC 
        Rag_NNP -_: /_NN -_: fetal_JJ thymocytes_NNS support_VBP the_DT
        hypothesis_NNS that_IN fetal_JJ thymocyte_NN maturation_NN is_VBZ fundamentally_RB
        different_JJ from_IN thymocyte_NN development_NN in_IN the_DT adult_NN thymus_JJ ._.
        The_DT TN_NNP 1_CD and_CC DP_NNP stages_NNS both_DT show_NN increased_VBN proliferation_NN in_IN
        wild-type_JJ fetal_JJ thymocytes_NNS compared_VBN to_TO adults_NNS ._. This_DT
        difference_NN at_IN the_DT TN_NNP 1_CD stage_NN is_VBZ not_RB due_JJ to_TO the_DT presence_NN of_IN
        more_JJR B_NNP or_CC NK_NNP cells_NNS in_IN the_DT adult_NN thymus_JJ ._. Although_IN it_PRP is_VBZ
        formally_RB possible_JJ that_IN some_DT other_JJ cell_NN type_NN may_MD still_RB be_VB
        included_VBN in_IN our_PRP$ TN_NNP 1_CD population_NN ,_, this_DT analysis_NN strongly_RB
        suggests_VBZ that_IN TN_NNP 1_CD cells_NNS have_VBP different_JJ proliferation_NN
        profiles_NNS in_IN fetal_JJ and_CC adult_NN thymus_JJ ._.
        It_PRP has_VBZ been_VBN well_RB documented_VBN that_IN thymocytes_NNS in_IN adult_NN 
        Rag_NNP 1_CD or_CC 
        Rag_NNP 2_CD mutants_NNS have_VBP dramatically_RB
        reduced_VBN proliferation_NN compared_VBN to_TO wild_JJ type_NN ,_, particularly_RB
        at_IN the_DT TN_NNP 3_CD stage_NN [_NN 37_CD 38_CD 39_CD 40_CD ]_NN ,_, and_CC Penit_NNP et_CC al_NN ._.
        reported_VBD 2_CD -_: 10_CD fold_VB reductions_NNS at_IN every_DT stage_NN of_IN thymocyte_NN
        development_NN in_IN 
        Rag_NNP -_: /_NN -_: adults_NNS [_NN 13_CD ]_NN ._. Recent_JJ work_NN by_IN
        Petrie_NNP ,_, et_CC al_NN ._. has_VBZ shown_VBN that_IN this_DT reduced_JJ proliferation_NN is_VBZ
        not_RB intrinsic_JJ to_TO 
        Rag_NNP mutant_JJ thymocytes_NNS ,_, but_CC rather_RB is_VBZ
        secondary_JJ to_TO thymic_JJ microenvironment_NN defects_NNS in_IN 
        Rag_NNP mutants_NNS [_NN 37_CD ]_NN ._. Our_PRP$ results_NNS show_VBP
        that_IN at_IN fetal_JJ stages_NNS ,_, 
        Rag_NNP mutant_JJ thymocytes_NNS have_VBP a_DT
        proliferation_NN profile_NN that_WDT is_VBZ much_RB more_RBR similar_JJ to_TO wild_JJ
        type_NN thymocytes_NNS at_IN the_DT same_JJ stage_NN ,_, with_IN less_JJR than_IN a_DT 2_CD -_: fold_VB
        difference_NN in_IN the_DT percentage_NN of_IN proliferating_VBG cells_NNS at_IN any_DT
        stage_NN ._. For_IN example_NN ,_, TN_NNP 3_CD stage_NN thymocytes_NNS in_IN the_DT 
        Rag_NNP -_: /_NN -_: adult_NN thymus_JJ have_VBP
        proliferation_NN levels_NNS 3_CD -_: fold_VB below_IN wild_JJ type_NN thymus_JJ [_NN 13_CD 37_CD
        ]_NN ,_, while_IN in_IN the_DT 
        Rag_NNP -_: /_NN -_: fetal_JJ thymus_JJ TN_NNP 3_CD cells_NNS are_VBP
        only_RB 25_CD -_: 30_CD %_NN lower_JJR than_IN in_IN wild_JJ type_NN fetal_JJ thymus_JJ ._.
        Proliferation_NNP is_VBZ not_RB changed_VBN at_IN all_DT stages_NNS ,_, and_CC is_VBZ actually_RB
        increased_VBN relative_JJ to_TO wild_JJ type_NN at_IN the_DT TN_NNP 2_CD stage_NN ._. This_DT
        increase_NN at_IN the_DT TN_NNP 2_CD stage_NN may_MD be_VB due_JJ to_TO the_DT failure_NN of_IN TN_NNP 2_CD
        cells_NNS to_TO initiate_VB TCRβ_NNP gene_NN rearrangement_NN at_IN this_DT stage_NN ,_,
        which_WDT is_VBZ normally_RB associated_VBN with_IN decreased_VBD proliferation_NN ._. 
        Rag_NNP -_: /_NN -_: mutants_NNS have_VBP a_DT profound_JJ
        thymocyte_NN development_NN block_NN at_IN the_DT TN_NNP 3_CD to_TO TN_NNP 4_CD /_NN preDP_NN
        transition_NN [_NN 51_CD ]_NN ._. During_IN normal_JJ wild_JJ type_NN fetal_JJ thymus_JJ
        development_NN ,_, significant_JJ DP_NNP cell_NN development_NN does_VBZ not_RB occur_VB
        until_IN E_NNP 16_CD ._. 5_LS in_IN most_JJS genetic_JJ backgrounds_NNS ._. As_IN a_DT result_NN ,_, at_IN
        E_NNP 17_CD ._. 5_LS the_DT thymic_JJ microenvironment_NN in_IN 
        Rag_NNP mutants_NNS has_VBZ not_RB been_VBN exposed_VBN to_TO
        abnormal_JJ thymocyte_NN development_NN for_IN very_RB long_JJ ,_, and_CC has_VBZ not_RB
        yet_RB developed_VBD the_DT full_JJ phenotype_NN seen_VBN in_IN the_DT steady_JJ state_NN
        adult_NN 
        Rag_NNP mutant_JJ thymus_JJ [_NN 35_CD ]_NN ._.
        In_IN the_DT 
        Hoxa_NNP 3_CD ,_, Pax_NNP 1_CD compound_NN mutants_NNS ,_,
        cell-autonomous_JJ TEC_NNP defects_NNS cause_VBP a_DT partial_JJ block_NN at_IN the_DT
        DN-DP_NNP transition_NN ,_, so_RB thymocytes_NNS do_VBP progress_VB to_TO DP_NNP and_CC SP_NNP
        stages_NNS ,_, albeit_IN at_IN reduced_VBN frequencies_NNS [_NN 29_CD ]_NN ._. TEC_NNP defects_NNS
        are_VBP seen_VBN as_RB early_RB as_IN E_NNP 12_CD ._. 5_LS in_IN these_DT mutants_NNS ,_, from_IN the_DT
        earliest_JJS stages_NNS of_IN organogenesis_NNS [_NN 34_CD ]_NN ._. Therefore_RB ,_, the_DT
        TEC_NNP defects_NNS in_IN these_DT mice_NNS would_MD be_VB expected_VBN to_TO have_VB
        different_JJ effects_NNS on_IN thymocyte_NN proliferation_NN than_IN in_IN 
        Rag_NNP mutants_NNS ._. In_IN this_DT study_NN ,_, we_PRP found_VBD
        stage-specific_JJ changes_NNS in_IN thymocyte_NN proliferation_NN at_IN the_DT DP_NNP
        stage_NN ._. Our_PRP$ previous_JJ analysis_NN reported_VBD decreased_VBN DP_NNP cell_NN
        number_NN and_CC increased_VBN apoptosis_NNS in_IN both_DT the_DT pre-_NN DP_NNP and_CC DP_NNP
        stages_NNS in_IN these_DT mutants_NNS [_NN 29_CD ]_NN ._. DP_NNP cell_NN numbers_NNS in_IN both_PDT
        this_DT and_CC our_PRP$ previous_JJ study_NN were_VBD decreased_VBN 10_CD -_: fold_VB in_IN the_DT 
        Hoxa_NNP 3_CD +_NN /_NN -_: 
        Pax_NNP 1_CD -_: /_NN -_: compound_NN mutants_NNS ._. At_IN first_JJ
        glance_NN ,_, the_DT increase_NN in_IN the_DT percentage_NN of_IN proliferating_VBG
        cells_NNS at_IN the_DT DP_NNP stage_NN appears_VBZ contradictory_JJ to_TO this_DT
        phenotype_NN ._. However_RB ,_, this_DT increase_NN actually_RB corresponds_NNS to_TO
        decreased_VBD numbers_NNS of_IN proliferating_VBG DP_NNP cells_NNS compared_VBN to_TO
        wild_JJ type_NN ._. In_IN contrast_NN ,_, pre-_NN DP_NNP cells_NNS did_VBD not_RB have_VB a_DT change_NN
        in_IN the_DT number_NN or_CC percentage_NN of_IN proliferating_VBG cells_NNS ,_,
        suggesting_VBG that_IN the_DT signals_NNS promoting_VBG proliferation_NN of_IN
        these_DT cells_NNS is_VBZ still_RB present_JJ ,_, and_CC that_DT proliferation_NN of_IN DP_NNP
        and_CC pre-_NN DP_NNP cells_NNS may_MD be_VB regulated_VBN independently_RB ._. Pre-_NNP DP_NNP
        cells_NNS do_VBP have_VBP a_DT three-fold_JJ increase_NN in_IN apoptosis_NNS [_NN 29_CD ]_NN ,_,
        suggesting_VBG that_IN separate_JJ signals_NNS regulate_VB proliferation_NN and_CC
        survival_NN of_IN these_DT cells_NNS ._. Combined_VBN with_IN our_PRP$ previous_JJ data_NNS ,_,
        this_DT result_NN suggests_VBZ that_IN the_DT decrease_NN in_IN DP_NNP cell_NN numbers_NNS
        seen_VBN in_IN the_DT 
        Hoxa_NNP 3_CD -_: Pax_NNP 1_CD compound_NN mutants_NNS is_VBZ both_DT
        due_NN to_TO an_DT increase_NN in_IN the_DT number_NN of_IN pre-_NN DP_NNP and_CC DP_NNP cells_NNS
        undergoing_VBG apoptosis_NNS as_RB well_RB as_IN a_DT decrease_NN in_IN the_DT number_NN of_IN
        proliferating_VBG DP_NNP ._.
        Insufficiencies_NNP of_IN multiple_JJ cytokines_NNS might_MD be_VB involved_VBN
        in_IN the_DT changes_NNS in_IN proliferation_NN and_CC cell_NN death_NN at_IN the_DT CD_NNP 44_CD
        -_: 25_CD -_: and_CC DP_NNP stages_NNS in_IN 
        Hoxa_NNP 3_CD -_: Pax_NNP 1_CD compound_NN mutants_NNS ._. SCF_NNP and_CC
        IL-_NNP 7_CD are_VBP first_RB expressed_VBN as_RB early_RB as_IN E_NNP 12_CD ._. 5_LS in_IN the_DT
        developing_VBG thymus_JJ ,_, well_RB before_IN significant_JJ thymocyte_NN
        maturation_NN takes_VBZ place_NN [_NN 52_CD 53_CD ]_NN ._. Although_IN the_DT number_NN of_IN
        TECs_NNP is_VBZ reduced_VBN by_IN about_IN 2_CD -_: fold_VB in_IN 
        Hoxa_NNP 3_CD +_NN /_NN -_: 
        Pax_NNP 1_CD -_: /_NN -_: compound_NN mutants_NNS ,_, the_DT number_NN
        of_IN thymocytes_NNS is_VBZ reduced_VBN by_IN a_DT slightly_RB greater_JJR amount_NN ,_,
        around_IN 3_CD -_: fold_VB [_NN 29_CD ]_NN ._. Therefore_RB ,_, the_DT reductions_NNS seen_VBN in_IN
        cytokine_NN message_NN levels_NNS in_IN the_DT 
        Hoxa_NNP 3_CD +_NN /_NN -_: 
        Pax_NNP 1_CD -_: /_NN -_: compound_NN mutants_NNS are_VBP not_RB
        secondary_JJ to_TO decreased_VBD TEC_NNP numbers_NNS ._. In_IN fact_NN ,_, these_DT mutants_NNS
        should_MD have_VB a_DT relative_JJ increase_NN in_IN the_DT proportion_NN of_IN TECs_NNP ,_,
        making_VBG the_DT reductions_NNS seen_VBN in_IN cytokine_NN levels_NNS in_IN the_DT mutant_JJ
        thymi_NN even_RB more_RBR striking_JJ ._. The_DT reduced_VBN expression_NN of_IN these_DT
        cytokines_NNS in_IN 
        Hoxa_NNP 3_CD +_NN /_NN -_: 
        Pax_NNP 1_CD -_: /_NN -_: compound_NN mutants_NNS could_MD be_VB an_DT
        indirect_JJ effect_NN of_IN defective_JJ TEC_NNP differentiation_NN ,_, or_CC could_MD
        be_VB direct_JJ downstream_JJ targets_NNS since_IN both_DT 
        Hoxa_NNP 3_CD and_CC 
        Pax_NNP 1_CD are_VBP expressed_VBN in_IN fetal_JJ thymus_JJ [_NN
        54_CD 55_CD ]_NN ._. Comparison_NNP of_IN the_DT 
        Hoxa_NNP 3_CD +_NN /_NN -_: 
        Pax_NNP 1_CD -_: /_NN -_: phenotype_NN with_IN those_DT of_IN
        cytokine_NN mutants_NNS do_VBP not_RB reveal_VB many_JJ similarities_NNS [_NN 30_CD 46_CD 56_CD
        57_CD 58_CD 59_CD 60_CD 61_CD ]_NN ,_, probably_RB because_IN of_IN the_DT simultaneous_JJ
        reductions_NNS in_IN multiple_JJ cytokines_NNS in_IN the_DT 
        Hoxa_NNP 3_CD +_NN /_NN -_: 
        Pax_NNP 1_CD -_: /_NN -_: mutants_NNS ._. For_IN example_NN ,_, SCF_NNP and_CC
        IL-_NNP 7_CD have_VBP been_VBN shown_VBN to_TO have_VB synergistic_JJ functions_NNS [_NN 62_CD 63_CD
        ]_NN ._. Therefore_RB ,_, changes_NNS in_IN multiple_JJ cytokines_NNS in_IN 
        Hoxa_NNP 3_CD +_NN /_NN -_: 
        Pax_NNP 1_CD -_: /_NN -_: mutants_NNS would_MD be_VB expected_VBN to_TO
        have_VB complex_JJ effects_NNS on_IN thymocyte_NN development_NN that_WDT could_MD be_VB
        difficult_JJ to_TO predict_VB ._.
        Interpretation_NNP of_IN the_DT observed_VBN phenotype_NN is_VBZ further_RBR
        complicated_VBN by_IN the_DT fact_NN that_DT none_NN of_IN the_DT cytokines_NNS tested_VBN
        are_VBP completely_RB absent_JJ ._. A_DT striking_JJ example_NN is_VBZ the_DT complete_JJ
        absence_NN of_IN γδTCR_NN +_NN thymocyte_NN development_NN in_IN IL-_NNP 7_CD mutants_NNS ,_, in_IN
        contrast_NN to_TO normal_JJ γδTCR_NN +_NN cell_NN development_NN in_IN 
        Hoxa_NNP 3_CD +_NN /_NN -_: 
        Pax_NNP 1_CD -_: /_NN -_: mutants_NNS [_NN 29_CD ]_NN ,_, which_WDT have_VBP
        dramatically_RB reduced_VBN IL-_NNP 7_CD levels_NNS ._. This_DT result_NN suggests_VBZ that_IN
        although_IN γδTCR_NN +_NN cell_NN development_NN requires_VBZ IL-_NNP 7_CD ,_, low_JJ levels_NNS
        are_VBP sufficient_JJ for_IN this_DT function_NN ._. Therefore_RB ,_, analysis_NN of_IN
        mutants_NNS with_IN low_JJ levels_NNS of_IN cytokines_NNS may_MD provide_VB a_DT system_NN
        for_IN uncovering_VBG both_DT dosage-dependent_JJ requirements_NNS and_CC later_RB
        functions_NNS for_IN these_DT factors_NNS in_IN promoting_VBG thymocyte_NN
        development_NN ._. It_PRP is_VBZ also_RB possible_JJ that_IN some_DT of_IN the_DT
        differences_NNS seen_VBN between_IN 
        Hoxa_NNP 3_CD +_NN /_NN -_: 
        Pax_NNP 1_CD -_: /_NN -_: and_CC cytokine_NN mutant_JJ
        phenotypes_NNS reflect_VBP different_JJ effects_NNS of_IN cytokines_NNS at_IN fetal_JJ
        and_CC adult_NN stages_NNS ._. Studies_NNS of_IN IL-_NNP 7_CD R_NN mutants_NNS showed_VBD
        relatively_RB normal_JJ thymocyte_NN maturation_NN at_IN fetal_JJ stages_NNS ,_,
        albeit_IN with_IN reduced_VBN thymocyte_NN numbers_NNS ,_, in_IN contrast_NN to_TO a_DT
        severe_JJ block_NN in_IN thymocyte_NN differentiation_NN in_IN adult_NN thymus_JJ [_NN
        49_CD ]_NN ._. Analysis_NNP of_IN cytokine_NN mutants_NNS during_IN fetal_JJ stages_NNS
        could_MD therefore_RB reveal_VB a_DT more_RBR complete_JJ picture_NN of_IN the_DT role_NN
        of_IN these_DT cytokines_NNS during_IN fetal_JJ thymus_JJ development_NN ._.
      
      
        Conclusions_NNP
        Our_PRP$ results_NNS show_VBP that_IN fetal_JJ and_CC adult_NN wild_JJ type_NN
        thymocytes_NNS have_VBP stage-specific_JJ differences_NNS in_IN
        proliferation_NN ,_, with_IN both_DT TN_NNP 1_CD and_CC DP_NNP cells_NNS exhibiting_VBG higher_JJR
        levels_NNS of_IN proliferation_NN in_IN fetal_JJ thymus_JJ ._. This_DT fetal_JJ
        wild-type_JJ profile_NN was_VBD very_RB similar_JJ to_TO that_DT seen_VBN for_IN fetal_JJ 
        Rag_NNP mutant_JJ thymocytes_NNS ,_, in_IN contrast_NN to_TO
        adult_NN 
        Rag_NNP -_: /_NN -_: thymus_JJ ._. Therefore_RB ,_, the_DT changes_NNS
        in_IN proliferation_NN seen_VBN in_IN the_DT fetal_JJ 
        Rag_NNP mutant_JJ thymocytes_NNS reflect_VBP the_DT
        earliest_JJS microenvironment_NN changes_NNS occurring_VBG as_IN a_DT result_NN of_IN
        defective_JJ TEC-thymocyte_NNP interactions_NNS in_IN the_DT 
        Rag_NNP -_: /_NN -_: thymus_JJ ._.
        The_DT current_JJ study_NN further_JJ supports_VBZ a_DT role_NN for_IN TECs_NNP in_IN
        regulating_VBG both_DT thymocyte_NN proliferation_NN and_CC survival_NN during_IN
        the_DT DN-DP_NNP transition_NN ,_, and_CC suggests_VBZ that_DT proliferation_NN and_CC
        apoptosis_NNS of_IN TN_NNP 4_CD and_CC DP_NNP cells_NNS are_VBP regulated_VBN independently_RB ._.
        Our_PRP$ results_NNS provide_VBP direct_JJ genetic_JJ evidence_NN for_IN these_DT
        functions_NNS of_IN TECs_NNP ,_, by_IN showing_VBG that_IN these_DT processes_NNS are_VBP
        defective_JJ in_IN mutants_NNS with_IN a_DT primary_JJ TEC_NNP differentiation_NN
        defect_NN (_( the_DT 
        Hoxa_NNP 3_CD ,_, Pax_NNP 1_CD compound_NN mutants_NNS )_) ._. Taken_VBN
        together_RB ,_, our_PRP$ results_NNS further_JJ define_VB the_DT role_NN TECs_NNP play_VB at_IN
        this_DT complex_JJ stage_NN of_IN thymocyte_NN development_NN ._.
      
      
        Methods_NNP
        
          Mice_NNS and_CC genotyping_VBG
          
          Hoxa_NNP 3_CD +_NN /_NN -_: 
          Pax_NNP 1_CD +_NN /_NN -_: mice_NNS were_VBD mated_VBN to_TO 
          Pax_NNP 1_CD +_NN /_NN -_: or_CC 
          Pax_NNP 1_CD -_: /_NN -_: mice_NNS and_CC genotyped_JJ for_IN both_DT
          
          Hoxa_NNP 3_CD and_CC 
          Pax_NNP 1_CD by_IN PCR_NNP as_IN described_VBN previously_RB
          [_NN 29_CD ]_NN ._. Comparisons_NNP were_VBD made_VBN between_IN littermates_NNS from_IN
          the_DT same_JJ colony_NN ._. 
          Rag_NNP 1_CD -_: /_NN -_: mice_NNS (_( Jackson_NNP Labs_NNPS )_) were_VBD
          maintained_VBN as_IN a_DT homozygous_JJ mutant_JJ colony_NN ._. All_DT mice_NNS were_VBD
          maintained_VBN as_IN congenic_JJ on_IN a_DT C_NNP 57_CD BL_NNP /_NN 6_CD genetic_JJ background_NN ._.
          Noon_NNP of_IN the_DT day_NN of_IN vaginal_JJ plug_NN was_VBD considered_VBN E_NNP 0_CD ._. 5_LS ._. All_DT
          animal_NN use_NN procedures_NNS were_VBD approved_VBN by_IN the_DT Medical_NNP
          College_NNP of_IN Georgia_NNP Committee_NNP on_IN Animal_NNP Use_NNP for_IN Research_NNP
          and_CC Education_NNP (_( CAURE_NNP )_) ._.
        
        
          Flow_NNP cytometry_NN
          Fetal_NNP thymocyte_NN in_IN vivo_NN BrdU_NNP incorporation_NN was_VBD done_VBN by_IN
          intraperitoneal_NN injection_NN of_IN BrdU_NNP
          (_( 5_CD -_: Bromo-_NNP 2_CD '_POS -_: Deoxyuridine_NNP ;_: Sigma_NNP )_) on_IN the_DT morning_NN of_IN E_NNP 17_CD ._. 5_LS ,_,
          two_CD doses_NNS per_IN mouse_NN and_CC 1_CD mg_NN per_IN dose_NN with_IN a_DT 0_CD ._. 5_CD hour_NN
          pause_NN ,_, as_RB previously_RB described_VBD [_NN 13_CD ]_NN ._. Two_CD hours_NNS after_IN
          the_DT first_JJ injection_NN ,_, fetal_JJ thymi_NN were_VBD isolated_VBN by_IN
          dissection_NN and_CC single-cell_JJ suspensions_NNS prepared_VBN by_IN
          passing_VBG the_DT thymocytes_NNS through_IN cell_NN strainers_NNS ._. Adult_NNP
          thymocyte_NN in_IN vivo_NN BrdU_NNP incorporation_NN was_VBD done_VBN by_IN the_DT same_JJ
          injection_NN protocol_NN using_VBG 6_CD -_: 8_CD week_NN old_JJ C_NNP 57_CD BL_NNP /_NN 6_CD adult_NN
          mice_NNS ._.
          Four-color_NNP flow_NN cytometry_NN was_VBD performed_VBN using_VBG the_DT
          following_NN monoclonal_NN antibodies_NNS (_( Pharmingen_NNP )_) :_: biotin_NN
          anti-mouse_JJ CD_NNP 25_CD (_( clone_NN :_: 7_CD D_NNP 4_LS )_) visualized_JJ with_IN Per-_NNP CP_NNP
          conjugated_JJ streptavidin_NN ;_: APC_NNP anti-mouse_JJ CD_NNP 44_CD (_( clone_NN :_:
          IM_NNP 7_CD )_) ;_: and_CC three_CD phycoerythrin_NN (_( PE_NNP )_) conjugated_JJ antibodies_NNS :_:
          anti-mouse_JJ CD_NNP 4_CD (_( clone_NN :_: RM_NNP 4_CD -_: 5_LS )_) ,_, anti-mouse_JJ CD_NNP 8_CD a_DT (_( clone_NN :_:
          53_CD -_: 6_CD ._. 7_CD )_) ,_, and_CC anti-mouse_JJ CD_NNP 3_CD ε_NN (_( clone_NN :_: 145_CD -_: 2_CD C_NNP 11_CD )_) ._. In_IN some_DT
          experiments_NNS ,_, PE_NNP conjugated_JJ antibodies_NNS against_IN B_NNP 220_CD
          (_( clone_NN :_: RA_NNP 3_CD -_: 6_CD B_NNP 2_LS )_) and_CC NK_NNP 1_CD ._. 1_LS (_( clone_NN :_: PK_NNP 136_CD )_) were_VBD also_RB
          included_VBN ._. After_IN cell_NN surface_NN staining_VBG ,_, the_DT cells_NNS were_VBD
          fixed_VBN with_IN 2_CD %_NN paraformaldehyde_NN (_( PFA_NNP )_) /_NN PBS_NNP at_IN 4_CD °_NN C_NNP
          overnight_JJ ._. The_DT cells_NNS were_VBD then_RB washed_VBN ,_, permeabilized_JJ with_IN
          0_CD ._. 1_CD %_NN Triton_NNP X-_NNP 100_CD /_NN 0_CD ._. 1_CD %_NN Na-_NNP Citrate_NNP (_( pH_NN 7_CD ._. 2_LS )_) on_IN ice_NN for_IN 2_CD
          min_NN ,_, and_CC then_RB treated_VBN with_IN 50_CD units_NNS of_IN DNaseI_NNP at_IN 37_CD °_NN C_NNP for_IN
          10_CD min_NN ._. Cells_NNP were_VBD then_RB stained_JJ with_IN FITC_NNP anti-_NN BrdU_NNP
          antibody_NN (_( Pharmingen_NNP )_) ._. Data_NNP were_VBD collected_VBN by_IN selectively_RB
          gating_VBG either_CC CD_NNP 3_CD -_: 4_CD -_: 8_CD -_: or_CC CD_NNP 3_CD +_NN 4_CD +_NN 8_CD +_NN populations_NNS
          (_( Becton_NNP Dickinson_NNP dual_JJ laser_NN FACSCalibur_NNP )_) ,_, and_CC analyses_NNS
          were_VBD performed_VBN with_IN Cellquest_NNP software_NN ._. Significant_JJ
          differences_NNS were_VBD determined_VBN by_IN the_DT unpaired_JJ Student_NNP 's_POS
          t-test_JJ or_CC ANOVA_NNP analysis_NN ._.
        
        
          Semi-quantitative_NNP RT-PCR_NNP
          E_NNP 14_CD ._. 5_LS fetal_JJ thymic_JJ lobes_NNS were_VBD collected_VBN and_CC stored_VBN in_IN
          the_DT TRIzol_NNP (_( GIBCO_NNP BRL_NNP )_) at_IN -_: 70_CD °_NN C_NNP until_IN RNA_NNP isolation_NN ._.
          Pools_NNP of_IN 5_CD -_: to_TO 10_CD thymi_NN from_IN embryos_NNS of_IN the_DT same_JJ genotype_NN
          were_VBD homogenized_JJ using_VBG Micro_NNP Pellet_NNP Pestles_NNP (_( Nalge_NNP Nunc_NNP
          International_NNP )_) in_IN 1_CD ._. 5_CD ml-eppendorf_JJ tubes_NNS ._. RNA_NNP was_VBD
          isolated_VBN and_CC the_DT genomic_JJ DNA_NNP was_VBD depleted_VBN by_IN using_VBG DNaseI_NNP
          (_( Amplification_NNP Grade_NNP ,_, GIBCO_NNP BRL_NNP )_) following_VBG the_DT
          manufacturer_NN 's_POS protocols_NNS ._. Reverse_VBP transcription_NN of_IN 1_CD μg_NN
          of_IN total_JJ RNA_NNP to_TO cDNA_NN was_VBD done_VBN using_VBG SuperScript_NNP II_NNP
          following_VBG the_DT manufacturer_NN 's_POS protocol_NN (_( GIBCO_NNP BRL_NNP )_) ._. Equal_NNP
          amounts_NNS of_IN cDNA_NN from_IN different_JJ genotypes_NNS were_VBD added_VBN to_TO a_DT
          final_JJ 20_CD μl_NN PCR_NNP reaction_NN mixture_NN using_VBG the_DT QIAGEN_NNP Taq_NNP PCR_NNP
          kits_NNS ._. PCR_NNP conditions_NNS were_VBD :_: 94_CD °_NN C_NNP 30_CD sec_NN ,_, 50_CD °_NN C_NNP 1_CD min_NN ,_, 72_CD °_NN C_NNP
          1_CD min_NN for_IN IL-_NNP 7_CD ,_, SCF_NNP and_CC their_PRP$ internal_JJ control_NN β-actin_JJ ;_:
          or_CC 94_CD °_NN C_NNP 30_CD sec_NN ,_, 60_CD °_NN C_NNP 1_CD min_NN ,_, 72_CD °_NN C_NNP 1_CD min_NN for_IN TGFβ_NNP 1_CD and_CC its_PRP$
          internal_JJ control_NN β-actin_JJ ._. PCR_NNP products_NNS were_VBD visualized_JJ by_IN
          5_CD %_NN acrylamide_NN gel_NN electrophoresis_NNS and_CC ethidium_NN bromide_NN
          staining_VBG ._. Band_NNP densities_NNS were_VBD measured_VBN and_CC analyzed_VBN using_VBG
          the_DT Molecular_NNP Analyst_NNP software_NN package_NN (_( Bio-_NNP Rad_NNP
          Laboratories_NNPS ,_, Version_NNP 1_CD ._. 4_CD ._. 1_LS )_) ._. Primer_NNP sequences_NNS were_VBD :_: IL-_NNP 7_CD
          [_NN 65_CD ]_NN :_: IL-_NNP 7_CD (_( 5_CD '_POS )_) 5_CD '_POS ACT_NNP ACA_NNP CCC_NNP ACC_NNP TCC_NNP CGC_NNP A_DT 3_CD '_POS ;_: IL-_NNP 7_CD
          (_( 3_CD '_POS )_) 5_CD '_POS TCT_NNP CAG_NNP TAG_NNP TCT_NNP CTT_NNP TAG_NNP G_NNP 3_CD '_POS ;_: SCF_NNP [_NN 65_CD ]_NN :_: SCF_NNP (_( 5_CD '_POS )_)
          5_CD '_POS TCT_NNP TCA_NNP ACT_NNP GCT_NNP CCT_NNP ATT_NNP T_NN 3_CD '_POS ;_: SCF_NNP (_( 3_CD '_POS )_) 5_CD '_POS ACT_NNP GCT_NNP ACT_NNP GCT_NNP
          GTC_NNP ATT_NNP C_NNP 3_CD '_POS ;_: TGFβ_NNP 1_CD [_NN 66_CD ]_NN :_: TGFβ_NNP 1_CD (_( 5_CD '_POS )_) 5_CD '_POS GCG_NNP GAC_NNP TAC_NNP TAT_NNP
          GCT_NNP AAA_NNP GAG_NNP G_NNP 3_CD '_POS ;_: TGFβ_NNP 1_CD (_( 3_CD '_POS )_) 5_CD '_POS GTT_NNP GTG_NNP TTG_NNP GTT_NNP GTA_NNP GAG_NNP GGC_NNP
          A_DT 3_CD '_POS ;_: β-actin_JJ [_NN 67_CD ]_NN :_: β-actin_JJ (_( 5_CD '_POS )_) 5_CD '_POS GGG_NNP TCA_NNP GAA_NNP GGA_NNP CTC_NNP
          CTA_NNP TG_NNP 3_CD '_POS ;_: β-actin_JJ (_( 3_CD '_POS )_) 5_CD '_POS GTA_NNP ACA_NNP ATG_NNP CCA_NNP TGT_NNP TCA_NNP
          AT_NNP 3_CD '_'' ._.
        
        
          Fetal_NNP thymic_JJ organ_NN culture_NN (_( FTOC_NNP )_)
          Thymic_NNP lobes_NNS were_VBD dissected_VBN from_IN E_NNP 15_CD ._. 5_LS embryos_NNS ._. The_DT
          two_CD lobes_NNS from_IN each_DT embryo_NN cultured_JJ separately_RB in_IN high_JJ
          oxygen_NN submersion_NN culture_NN as_RB previously_RB described_VBD [_NN 41_CD ]_NN
          ._. Fetal_NNP thymic_JJ organ_NN cultures_NNS were_VBD supplemented_JJ with_IN 100_CD
          u_NN /_NN ml_NN of_IN IL-_NNP 7_CD or_CC 20_CD ng_NN /_NN ml_NN of_IN SCF_NNP (_( Pepro_NNP Tech_NNP Inc_NNP ._. )_) as_RB
          previously_RB described_VBD [_NN 41_CD ]_NN ._. For_IN each_DT embryo_NN ,_, one_CD lobe_NN
          was_VBD treated_VBN while_IN the_DT other_JJ was_VBD cultured_JJ in_IN parallel_JJ
          without_IN supplemental_JJ cytokine_NN as_IN an_DT internal_JJ control_NN ._. In_IN
          control_NN experiments_NNS ,_, lobes_NNS were_VBD cultured_JJ separately_RB under_IN
          identical_JJ conditions_NNS without_IN cytokine_NN ._. After_IN five_CD days_NNS in_IN
          culture_NN ,_, the_DT cells_NNS were_VBD stained_JJ by_IN PE-anti-mouse_NNP CD_NNP 4_CD and_CC
          FITC-anti-mouse_NNP CD_NNP 8_CD and_CC analyzed_VBN by_IN flow_NN cytometry_NN as_IN
          above_IN ._.
        
      
      
        Authors_NNP '_'' contributions_NNS
        DMS_NNP conceived_VBD of_IN the_DT study_NN and_CC performed_VBD all_DT of_IN the_DT
        experiments_NNS described_VBD ._. NRM_NNP contributed_VBD to_TO the_DT design_NN of_IN the_DT
        study_NN and_CC data_NNS analysis_NN ,_, and_CC drafted_VBD the_DT manuscript_NN ._.
        All_DT authors_NNS read_VBP and_CC approved_VBD the_DT final_JJ manuscript_NN ._.
      
    
  
